COMMUNIQUÉS West-GlobeNewswire
-
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
16/04/2026 -
New National Platform Launches to Bridge the Gap in Bereavement Care: Introducing GriefSupportDirectory.com
16/04/2026 -
AB Science provides an update on its clinical development program.
16/04/2026 -
AB Science fait le point sur son programme de développement clinique
16/04/2026 -
ProtoFlow Claims Evaluated: The High Potency Prostate Support Ingredients for Day & Night Relief
16/04/2026 -
Somnee Smart Sleep Headband Claims Evaluated: Does It Work? Wearable Tech for Restorative Rest Support
16/04/2026 -
Wake Radiology "Steps Up to the Plate" for Susan G. Komen Triangle Race for the Cure
16/04/2026 -
Disclosure of transparency notifications from BlackRock, Inc.
16/04/2026 -
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
16/04/2026 -
Virbac: forte croissance de +7,7 % au premier trimestre 2026 à pcc, portée par la croissance à deux chiffres de nos plateformes prioritaires Supercharge⁴
16/04/2026 -
Evaxion concludes Annual General Meeting
16/04/2026 -
Diverge Health adds Oakland Southfield Physicians in Michigan to List of Physician Organization Partners
16/04/2026 -
Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit
16/04/2026 -
Purisaki Berberine Patches 2026 | Effective Weight Loss For Women Lose 12+ lbs per Month Read Benefits, Ingredients, Side Effects, Lunch in USA.
16/04/2026 -
Confidential Care to Provide BraveMind Virtual Reality Treatment to Veterans
16/04/2026 -
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
16/04/2026 -
NBPure Launches at Target, Marking Major Retail Expansion
16/04/2026 -
Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership
16/04/2026 -
Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
16/04/2026
Pages